PMA
P010062: EUCLID SYSTEMS ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENS FOR OVERNIGHT WEAR
FDA PMA · Lens, contact, orthokeratology, overnight · Bausch & Lomb
Key facts
| PMA number | P010062 |
|---|---|
| Trade name | EUCLID SYSTEMS ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENS FOR OVERNIGHT WEAR |
| Generic name | Lens, contact, orthokeratology, overnight |
| Applicant | Bausch & Lomb |
| Owner/operator | Bausch & Lomb Incorporated |
| Product code | NUU |
| Approval date | Jun 7, 2004 |
| Docket number | 04M-0260 |
| Notice date | Jun 14, 2004 |
| Establishment registration | 1313525 |
| FEI number | 1317628 |
At a glance
- 10–99 Supplements
- Dec 16, 2025 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: